222 related articles for article (PubMed ID: 17954056)
1. Role of endothelin-1 receptor antagonists in vasoconstriction mediated by endothelin and other vasoconstrictors in human internal mammary artery.
He GW; Liu MH; Yang Q; Furnary A; Yim AP
Ann Thorac Surg; 2007 Nov; 84(5):1522-7. PubMed ID: 17954056
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor blockade improves endothelial function in human internal mammary arteries.
Verma S; Lovren F; Dumont AS; Mather KJ; Maitland A; Kieser TM; Kidd W; McNeill JH; Stewart DJ; Triggle CR; Anderson TJ
Cardiovasc Res; 2001 Jan; 49(1):146-51. PubMed ID: 11121806
[TBL] [Abstract][Full Text] [Related]
3. Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors.
Just A; Olson AJ; Arendshorst WJ
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F660-8. PubMed ID: 14678950
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-B-receptor-selective antagonist inhibits endothelin-1 induced potentiation on the vasoconstriction to noradrenaline and angiotensin II.
Gössl M; Mitchell A; Lerman A; Opazo Saez A; Schäfers RF; Erbel R; Philipp T; Wenzel RR
J Hypertens; 2004 Oct; 22(10):1909-16. PubMed ID: 15361762
[TBL] [Abstract][Full Text] [Related]
5. Intraindividual comparison of human radial and internal thoracic arteries in vitro and the effect of preoperative calcium blocker therapy.
Grapow MT; Reineke DC; Kern T; Antona C; Gelpi G; Santoli E; Zerkowski HR; Carrel TP; Müller-Schweinitzer E
Fundam Clin Pharmacol; 2007 Feb; 21(1):67-74. PubMed ID: 17227446
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vasoconstriction by angiotensin receptor antagonist GR117289C in arterial grafts.
Liu MH; Floten HS; Furnary AP; Yim AP; He GW
Ann Thorac Surg; 2000 Dec; 70(6):2064-9. PubMed ID: 11156121
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists.
Awane-Igata Y; Ikeda S; Watanabe T
Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts.
Liu MH; Floten SH; Yang Q; He GW
Br J Clin Pharmacol; 2001 Sep; 52(3):279-87. PubMed ID: 11560560
[TBL] [Abstract][Full Text] [Related]
9. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries.
Mickley EJ; Gray GA; Webb DJ
Br J Pharmacol; 1997 Apr; 120(7):1376-82. PubMed ID: 9105715
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man.
Wenzel RR; Rüthemann J; Bruck H; Schäfers RF; Michel MC; Philipp T
Br J Clin Pharmacol; 2001 Aug; 52(2):151-7. PubMed ID: 11488771
[TBL] [Abstract][Full Text] [Related]
11. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
[TBL] [Abstract][Full Text] [Related]
12. Effects of potassium channel opener aprikalim on the receptor-mediated vasoconstriction in the human internal mammary artery.
Liu MH; Floten HS; Furnary AP; Yim AP; He GW
Ann Thorac Surg; 2001 Feb; 71(2):636-41. PubMed ID: 11235720
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of vasoconstriction by potassium channel opener aprikalim in human conduit arteries used as bypass grafts.
He GW; Yang CQ
Br J Clin Pharmacol; 1997 Oct; 44(4):353-9. PubMed ID: 9354310
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 increases superoxide production in human coronary artery bypass grafts.
Cerrato R; Cunnington C; Crabtree MJ; Antoniades C; Pernow J; Channon KM; Böhm F
Life Sci; 2012 Oct; 91(13-14):723-8. PubMed ID: 22483692
[TBL] [Abstract][Full Text] [Related]
15. Unique response of human arteries to endothelin B receptor agonist and antagonist.
Liu JJ; Chen JR; Buxton BF
Clin Sci (Lond); 1996 Feb; 90(2):91-6. PubMed ID: 8829886
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts.
He GW; Yang CQ
J Cardiovasc Pharmacol; 1996 Aug; 28(2):208-14. PubMed ID: 8856475
[TBL] [Abstract][Full Text] [Related]
17. The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles.
Donato AJ; Lesniewski LA; Delp MD
Cardiovasc Res; 2005 May; 66(2):393-401. PubMed ID: 15820208
[TBL] [Abstract][Full Text] [Related]
18. Overview of the nature of vasoconstriction in arterial grafts for coronary operations.
He GW; Yang CQ; Starr A
Ann Thorac Surg; 1995 Mar; 59(3):676-83. PubMed ID: 7887711
[TBL] [Abstract][Full Text] [Related]
19. Effect of Benidipine in Human Internal Mammary Artery and Clinical Implications.
Hou HT; Wang J; Wang ZQ; Liu XC; Marinko M; Novakovic A; Yang Q; He GW
Ann Thorac Surg; 2016 May; 101(5):1789-95. PubMed ID: 26707005
[TBL] [Abstract][Full Text] [Related]
20. Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and alpha1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes.
Bender SB; Klabunde RE
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2281-8. PubMed ID: 17660396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
